(PAHs), nitrosamines, mycotoxins, aromatic amines, heterocyclic amines, ultraviolet light, and alkylating cancer chemotherapeutic agents. Most human DNA adduct exposure monitoring has been performed with either 32P-postlabeling or immunoassays, neither of which is able to chemically characterize specific DNA adducts. Recently developed combinations of methods with chemical and physical end points have allowed identification of specific adducts in human tissues.
Introduction
A large body of evidence in experimental promising biomarker for elucidating the systems suggests that DNA adduct forma-molecular epidemiology of cancer (3, 4) . tion is necessary, but not sufficient, for Classes of compounds for which human tumorigenesis caused by genotoxic chemi-DNA adducts have been measured include cal carcinogens (1, 2 poirierm@dc37a.nci.nih.gov Abbreviations used: AHH, aryl hydrocarbon hydroxylase; 3me-or 3et-Ade, 3-methyl- or 3-ethyladenine; 3OHet-Ade, 3-hydroxyethyladenine; 3bz-Ade, 3-benzyladenine; AFBj, aflatoxin B1; AFB1-N7-dG, aflatoxin Bj-N7-deoxyguanosine; AAS, atomic absorbance spectrometry; B[a]P, benzo[alpyrene; BPDE, r-7,t--dihydroxy-c-9,10-epoxy-7,8,9, 1 0-tetrahydrobenzolalpyrene; BPdG, (7R)-N241 0-[r-7, t-8, t-9-trihydroxy-7,8,9, 1 0-tetrahydrobenzo[alpyrenelyl}-deoxyguanosine; BP-7,1 0/8,9-tetrol, r-7, t-8, t-9,c-1 0-tetrahydroxy-7,8,9, 1 0-tetrahydro-benzo[alpyrene; carboplatin, diamminecyclobutanedicarboxylatoplatinum (11) ; cisplatin, cis-diamminedichloroplatinum (Il); dG-C8-4-ABP, N-deoxyguanosin-(8-yl)-4-aminobiphenyl; ECC, electrochemical conductance; ELISA, enzyme-linked immunosorbent assay; GC-MS, gas chromatography-mass spectrometry; HPLC, high performance liquid chromatography; 80H-dG, 8 -hydroxydeoxyguanosine; IAC, immunoaffinity chromatography; MOCA, 4,4'-methylene-bis(2-chloroaniline); N7OHet-dG, N7-hydroxyethyldeoxyguanosine; N7me-or N7et-dG, N7-methyl-or N7-ethyldeoxyguanosine; N N K, 4-(N-nitrosomethylamino)-1 -(3-pyridyl)-1 -butanone; 06me-or 06et-dG, 06-methyl-or ethyideoxyguanosine; 04me -or 04et-dT, 04-methyl-or ethylthymidine; PAHs, polycyclic aromatic hydrocarbons; PhIP, 2-amino-i-methyl-6-phenylimidazo [4,5- blpyridine; RIA, radioimmunoassay; SFS, synchronous fluorescence spectrometry; TLC, thin layer chromatography; UV, ultraviolet. and alkylating cancer chemotherapeutic agents. Human exposures that result in DNA adduct formation are listed in Tables  1 and 2 , and some chemical structures of DNA adducts are shown in Figure 1 . It is generally considered that DNA adduct formation represents biologically effective dose, or dose reaching a target tissue, and it is assumed that DNA adduct measurements have the potential to become integral components of the risk-assessment process. At the present time many technological approaches have sufficient sensitivity to measure human DNA adducts and are being used widely for exposure assessment. The advancement of the field to DNA adduct-based cancer risk assessment requires the implementation of adduct measurements within epidemiologically sound study designs, an area that is still in the early stages of development. It is also possible that toxic, but noncarcinogenic, compounds form DNA adducts and may have other adverse health outcomes for which DNA adduct formation may therefore be an appropriate biomarker.
Methods that have been used for sensitive detection of carcinogen-DNA adducts in humans include immunoassays (5), immunohistochemistry (6,7), 32p_ postlabeling, (8, 9) , fluorescence and phosphorescence spectroscopy (10), gas chromatography-mass spectrometry (GC-MS) (11), atomic absorbance spectrometry (AAS) (12, 13) and electrochemical conductance (ECC) (14 (15) (16) (17) have been widely used to quantify and localize xenobiotic-induced DNA damage (18) (19) (20) (21) and to measure DNA adduct formation in human tissues (22, 23 these are termed "aromatic adducts." The chemical identification of such adducts has rarely been achieved, but recent sophisticated modifications to the basic methodology have allowed tentative identification of some specific adducts (30, 50, 51) . Overall, correlations of adduct levels with documented human exposure appear to be good (52) (53) (54) (55) (56) , but the quantitative data should be interpreted with caution because the adducts are unidentified and the efficiency of phosphorylation is often unknown and uncontrolled (51, (57) (58) (59) (60) (Table 2 ). Alkyl purine adducts in human hr) of the urine have been the most extensively studresidues as ied (11, 72, 73, (77) (78) (79) (80) . These investigations 7,8,9,10-have examined the exfoliation of adducts -7,10/8,9-by seeking the presence of N7me-dG, adduct in N7et-dG, N7-hydroxethyldeoxyguas has been nosine (N7-OHet-dG), 3-methyladenine -66).
(3me-Ade), 3-ethyladenine (3et-Ade), 3--h involves hydroxyethyladenine (3OHet-Ade), and 3-trix phos-benzyladenine (3bz-Ade) in human urine. Ietect BP-Investigations using single-ion monitoring ses a solid GC-MS have been extended to the meacyclodex-surement of 4-(N-nitrosomethylamino)-1-ollowed by (3-pyridyl)-1-butanone (NNK) adducts in e limit of human lung and tracheal DNA of smokers wer than and nonsmokers (81) . In addition, the presence of BPdG has been demonstrated the use of in placental tissues of smokers and nondetection smokers (82) . Samples of human urinary iumans are bladder and lung DNA, digested and subuct chem-jected to negative ion GC-MS, were shown adduct be to contain N-deoxyguanosin-(8-yl)-4-t for rela-aminobiphenyl (dG-C8-4-ABP) at levels ple DNA that compared well with 32P-postlabeling cost of the analysis of the same samples using approerformed priate standards (83) . Similarly, the C-8 ate (Table DNA adduct of the heterocyclic amine i restricted 2-amino-1-methyl-6-phenylimidazontaining a [4,5-b] pyridine (PhIP) was observed by tection of GC-MS after hydrolysis from human rine (69), colon (84 (14) . However, factors related to the chromatographic conditions (gradient elution, temperature, and pressure) may cause problems with detector performance (90, 91) . Electrochemical conductance has been used to monitor oxidative damage in DNA (Table 2 ). This use of the method is complicated by the fact that oxidation of DNA may occur during the extraction procedure (92) ; however, 8-hydroxydeoxyguanosine (80H-dG) is detectable, whereas unmodified deoxyguanosine is not. The approach is sufficiently specific and sensitive for human biomonitoring, but investigations so far have been limited to determining 80H-dG in urine, peripheral white blood cells, or bronchial alveolar macrophages (93, 94) .
Combinations of Methods
The most frequently applied detection methods, immunoassays, 32P-postlabeling, and fluorescence spectroscopy, used in the absence of micropreparative techniques, provide a broad screen and indicate exposure. However, recently devised combinations of methods produce more specific and readily comprehensible data. Such approaches are necessarily more labor intensive, time consuming, expensive, and demanding when applied to large numbers of specimens, but the information they provide is invaluable for human exposure assessment.
Most combinations of methods to improve the specificity of DNA adduct detection use either conventional chromatographic separation or immunoaffinity chromatography as a first step. When a human DNA sample is digested and subjected to HPLC, even though the adducts cannot be observed by conventional monitoring, the fractions known to contain specific adducts can be analyzed by immunoassay, 32P-postlabeling, or GC-MS. For example, the sensitivity and specificity of ELISAs for human DNA adduct monitoring have been enhanced by combination with prior HPLC. This approach has been applied to human gastric mucosa (32) and liver samples (33) using antisera specific for alkyl-modified nucleosides. Chromatographic separation by HPLC has also been combined with 32P-postlabeling; a recent review (59) covers the subject. A highly successful line of experimentation has combined two chromatographic steps with 32p_ postlabeling to detect specific o6-and N7-alkyl-dG adducts in human lung and lymphocytes (51, 57, 95) . The development of this method has facilitated the use of internal and cochromatography standards. In an another approach, Stillwell et al. (79) employed two chromatographic steps prior to the GC-MS determination of 3me-dA and 7me-dG adducts in the urine of smokers. Finally, in a novel set of experiments, HPLC was used as the first step of a procedure combining 32P-postlabeling with immunoprecipitation (termed PREPI) for the detection of 06me-dG, 04me-dG, and 04et-dG in human liver and leukocyte DNA samples (50) .
Immunoaffinity chromatography provides a valuable purification step that has been widely used to improve the specificity of other methods. Antibodies elicited against DNA adducts or carcinogenmodified DNA samples can be covalently bound to a matrix and the resulting material used in columns that bind and elute specific adducts in a DNA digest. Because most antisera have cross-reactivity for families of structurally similar DNA adducts, IAC concentrates structurally similar DNA adducts (96) (97) (98) PAH-DNA adduct levels were measured in the same workers after time spent on vacation (105) .
In a study of U.S. Army soldiers, military personnel were monitored before, during, and after a tour of duty in Kuwait (106) . It was expected that higher exposure to PAHs would result from oil-well fires burning at that time. However, the DNA adduct and air sampling data indicate that these soldiers went from a clean environment in Kuwait in August to significantly higher pollution levels in Germany in October, and DNA adducts, assayed by both BPdG-DNA dissociation-enhanced lanhtanide fluoroimmunoassay and 32p-postlabeling, increased significantly (106) .
Another example of pollution modulation and concomitant reduction in DNA adduct levels occurred in the Silesian region of Poland in the summertime; the air was approximately 5-fold cleaner than in the winter, and the levels of adducts in lymphocytes was approximately 5-fold lower (107) . One should note, however, that the adduct dosimetry shown here to reflect ambient PAH levels is not consistent with the much higher levels of ambient B[a]P and the disproportionately low adduct levels observed in other studies (Table 3) .
Of all the studies summarized in Table  3 (110) . Of these, neither Dutch coke oven workers nor Chinese women had proportionately higher DNA adduct levels. The Chinese women, who have a high lung cancer risk, were exposed to coal smoke while cooking meals (108) , but the Dutch workers experienced 100 to 7800 ng/m3 during a 40-hr week (109) . Therefore, in analyzing these data, a number of confounding factors must be recognized. The use of ambient B[a]P measurements provide an indicator of the pollution levels, but the actual hydrocarbon components vary and are not always measured. The BPdG-DNA immunoassays used actually measure BPdG as well as a broad spectrum of PAH-DNA adducts, since the antiserum used in many studies (96, 111, 112) recognizes multiple PAH-DNA adducts (98 For dosimetry of aflatoxin exposure, 42 individuals in the Guangxi region of China were studied (103) . Samples of the food consumed were assayed for aflatoxin content, which was correlated with the urinary excretion of aflatoxin-N7-guanine (AFB1-N7-G) by both males and females. Immunoaffinity chromatography and HPLC were used to isolate metabolites and adducts from urine (28, 114) and fluorescence emission spectra were used to identify the AFB1-N7-G. The dosimetry data showed an excellent correlation between dietary aflatoxin intake and urinary adduct excretion (69) .
Cancer chemotherapy has presented unique opportunities to demonstrate DNA adduct dosimetry because the doses of drug are precisely known. Analysis of blood-cell DNA from 77 previously untreated ovarian and testicular cancer patients receiving platinum drug-based therapy showed strong DNA adduct dosimetry in patients with measurable DNA adduct levels (115, 116) . In studies with procarbazine and dacarbazine, which were used to treat patients with Hodgkin's lymphoma, an excellent correlation was shown between cumulative drug dose and blood-cell DNA levels of the O6me-dG adduct (39,117). In general, the presence of high levels of DNA adducts appears to correlate positively with favorable clinical outcome (118) , and therefore such analyses may become important clinical dosimeters. In addition, they serve to validate the assays commonly used for human DNA adduct measurements, since precise dosimetry is rarely possible in a clinical setting.
Correlation of DNA Adducts with Other Biomarkers
The classes of biomarkers most likely to correlate with PAH-DNA adduct measurements are urinary metabolites (biomarkers of exposure), hemoglobin adducts (surrogates for DNA adducts), mutagenesis (biomarkers of effect), and polymorphisms for enzymes involved in PAH metabolism (biomarkers of susceptibility). Studies currently available in this area have been performed with small numbers of subjects, and conflicting correlations have sometimes been observed. However, as methodological advances improve the specificity of biomarker analysis, there is the promise that batteries of such assays may be usefully employed in future risk assessments.
Metabolic polymorphisms are considered to influence all the other classes of biomarkers. The enzyme complex responsible for the initial metabolism of PAHs, aryl hydrocarbon hydroxylase (AHH), consists of a battery of enzymes that include cytochrome P4501A1. The extent of AHH activity in human lung microsomes has been compared to DNA adduct levels determined in the same lung samples by either HPLC and fluorescence (specific for BPdG) (119) or 32P-postlabeling (53) .
Both DNA adduct detection methods yielded results that correlated positively with the extent of AHH activity. Correlations of blood-cell DNA adduct levels with CYPlAl have been examined in chimney sweeps (155) and in California firefighters (156) with ambivalent results. The lack of agreement may be due to differences in experimental approaches to determining polymorphism and to detecting DNA adducts, but it is also possible that neither study had sufficient statistical power to demonstrate subtle effects.
Another metabolic enzyme class, the glutathione S-transferases (GSTs), is involved in PAH detoxification. An (122) . In one study, PAH-DNA adducts and 1-OH-pyrene were measured in Finnish Foundry workers at three levels of ambient B[a]P exposure (41), and whereas adducts did correlate with exposure, the urinary metabolite did not. Subsequently, analytical procedures have been developed for the BP-7,10/8,9-tetrol (123) and the 1-OH-pyrene glucuronide (124) , and these are now being measured in conjunction with DNA adducts (106) . A number of methodological approaches for PAH analysis of human hemoglobin have demonstrated the presence of adducts derived from B[a]P and chrysene (66, 125, 126) . Hemoglobin adducts of B[a]P were measured concomitantly with airborne PAH concentration in one study (127) , and a weak correlation was demonstrated with exposure, but DNA adducts were not measured. Attempts have been made to correlate HPRT mutagenesis with exposure and DNA adduct formation in Finnish foundry workers (128, 129) . There was a significant increase in HPRT mutagenesis and DNA adduct formation with exposure, but the numbers of individuals in the mutagenesis portion of the study were small (128) and the correlation requires more substantial validation.
Taken together, these results demonstrate that multiple biomarker correlations are not necessarily straightforward. The tissues studied, the nature of the parameters being measured, and the capabilities of the assays used should all be carefully scrutinized. The numbers of subjects available may be insufficient for solid statistics, and the validity of a particular correlation may not be established until after several independent investigations are performed. However, the present status of development of several biomarkers suggests that good correlation studies with PAH-DNA adduct measurements can now be designed. 
Conclusion

